These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome. Arroyo V, Terra C, Ginès P. J Hepatol; 2007 May; 46(5):935-46. PubMed ID: 17391801 [No Abstract] [Full Text] [Related]
23. An update on the pathogenesis and clinical management of cirrhosis with refractory ascites. Neong SF, Adebayo D, Wong F. Expert Rev Gastroenterol Hepatol; 2019 Apr; 13(4):293-305. PubMed ID: 30791777 [Abstract] [Full Text] [Related]
24. Pathophysiology, diagnosis and clinical management of hepatorenal syndrome: from classic to new drugs. Barbano B, Sardo L, Gigante A, Gasperini ML, Liberatori M, Giraldi GD, Lacanna A, Amoroso A, Cianci R. Curr Vasc Pharmacol; 2014 Jan; 12(1):125-35. PubMed ID: 24678726 [Abstract] [Full Text] [Related]